These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8905027)

  • 1. Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy.
    Pelosio P; Barbareschi M; Bonoldi E; Marchetti A; Verderio P; Caffo O; Bevilacqua P; Boracchi P; Buttitta F; Barbazza R; Dalla Palma P; Gasparini G
    Ann Oncol; 1996 Sep; 7(7):695-703. PubMed ID: 8905027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients.
    Gasparini G; Toi M; Verderio P; Ranieri G; Dante S; Bonoldi E; Boracchi P; Fanelli M; Tominaga T
    Int J Oncol; 1998 May; 12(5):1117-25. PubMed ID: 9538138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer.
    Michalides R; Hageman P; van Tinteren H; Houben L; Wientjens E; Klompmaker R; Peterse J
    Br J Cancer; 1996 Mar; 73(6):728-34. PubMed ID: 8611372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of molecular biomarkers in primary breast tumors implanted into a surrogate host: increased levels of cyclins correlate with tumor progression.
    Wani G; Noyes I; Milo GE; D'Ambrosio SM
    Mol Med; 1997 Apr; 3(4):273-83. PubMed ID: 9131589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
    Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
    Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 and prognosis in human breast cancer.
    Gillett C; Smith P; Gregory W; Richards M; Millis R; Peters G; Barnes D
    Int J Cancer; 1996 Apr; 69(2):92-9. PubMed ID: 8608989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.
    van Diest PJ; Michalides RJ; Jannink L; van der Valk P; Peterse HL; de Jong JS; Meijer CJ; Baak JP
    Am J Pathol; 1997 Feb; 150(2):705-11. PubMed ID: 9033283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
    Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
    Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
    Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A
    Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patients.
    Gasparini G; Fox SB; Verderio P; Bonoldi E; Bevilacqua P; Boracchi P; Dante S; Marubini E; Harris AL
    Clin Cancer Res; 1996 Jul; 2(7):1191-8. PubMed ID: 9816287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
    Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Ross JS
    Cancer; 1997 Aug; 80(4):753-63. PubMed ID: 9264360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients.
    Reed W; Flørems VA; Holm R; Hannisdal E; Nesland JM
    Virchows Arch; 1999 Aug; 435(2):116-24. PubMed ID: 10599310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors.
    Courjal F; Louason G; Speiser P; Katsaros D; Zeillinger R; Theillet C
    Int J Cancer; 1996 Aug; 69(4):247-53. PubMed ID: 8797862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis.
    Pellikainen MJ; Pekola TT; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    J Clin Pathol; 2003 Mar; 56(3):214-20. PubMed ID: 12610102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of combined analysis of cyclin D1 and estrogen receptor status in breast cancer patients.
    Hwang TS; Han HS; Hong YC; Lee HJ; Paik NS
    Pathol Int; 2003 Feb; 53(2):74-80. PubMed ID: 12588434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21(waf) correlates with DNA replication but not with prognosis in invasive breast cancer.
    Göhring UJ; Bersch A; Becker M; Neuhaus W; Schöndorf T
    J Clin Pathol; 2001 Nov; 54(11):866-70. PubMed ID: 11684722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma--results of a multiparametric study.
    Bevilacqua P; Barbareschi M; Verderio P; Boracchi P; Caffo O; Dalla Palma P; Meli S; Weidner N; Gasparini G
    Breast Cancer Res Treat; 1995; 36(2):205-17. PubMed ID: 8534868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma.
    van der Vegt B; de Roos MA; Peterse JL; Patriarca C; Hilkens J; de Bock GH; Wesseling J
    Histopathology; 2007 Sep; 51(3):322-35. PubMed ID: 17645748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.